BEN vs FDMT · P/E 36, rev $8.77B vs rev $37.0K
Franklin Resources Inc (BEN) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the BEN and FDMT stock pages for the full models.
Not investment advice.